View in EDS HTML Full Text

Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.

Saved in:
Bibliographic Details
Title: Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.
Authors: Hoechstetter MA; Department of Hematology, Oncology, Immunology, Palliative Medicine, Infectiology and Tropical Medicine, München Klinik Schwabing, Munich, Germany. Electronic address: manuela.hoechstetter@muenchen-klinik.de., Knauf W; Centrum für Hämatologie und Onkologie Bethanien, Hematology and Oncology Private Practice, Frankfurt, Germany., Dambacher S; Gilead Sciences, Inc., Foster City, California, USA., Hucke N; Gilead Sciences, Inc., Foster City, California, USA., Höhne K; Gilead Sciences, Inc., Foster City, California, USA., van Troostenburg A; Gilead Sciences, Inc., Foster City, California, USA., Ramroth H; Gilead Sciences, Inc., Foster City, California, USA., Abenhardt W; Hematology and Oncology Private Practice, Gilching, Germany., Rummel M; Department of Hematology and Oncology, University Hospital of the Justus-Liebig-University, Giessen, Germany.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. e777-e787. Date of Electronic Publication: 2022 Apr 09.
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35624058
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hoechstetter+MA%22">Hoechstetter MA</searchLink>; Department of Hematology, Oncology, Immunology, Palliative Medicine, Infectiology and Tropical Medicine, München Klinik Schwabing, Munich, Germany. Electronic address: manuela.hoechstetter@muenchen-klinik.de.<br /><searchLink fieldCode="AU" term="%22Knauf+W%22">Knauf W</searchLink>; Centrum für Hämatologie und Onkologie Bethanien, Hematology and Oncology Private Practice, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Dambacher+S%22">Dambacher S</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Hucke+N%22">Hucke N</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Höhne+K%22">Höhne K</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22van+Troostenburg+A%22">van Troostenburg A</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Ramroth+H%22">Ramroth H</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Abenhardt+W%22">Abenhardt W</searchLink>; Hematology and Oncology Private Practice, Gilching, Germany.<br /><searchLink fieldCode="AU" term="%22Rummel+M%22">Rummel M</searchLink>; Department of Hematology and Oncology, University Hospital of the Justus-Liebig-University, Giessen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. e777-e787. <i>Date of Electronic Publication: </i>2022 Apr 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35624058
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clml.2022.04.007
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e777
    Titles:
      – TitleFull: Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hoechstetter MA
      – PersonEntity:
          Name:
            NameFull: Knauf W
      – PersonEntity:
          Name:
            NameFull: Dambacher S
      – PersonEntity:
          Name:
            NameFull: Hucke N
      – PersonEntity:
          Name:
            NameFull: Höhne K
      – PersonEntity:
          Name:
            NameFull: van Troostenburg A
      – PersonEntity:
          Name:
            NameFull: Ramroth H
      – PersonEntity:
          Name:
            NameFull: Abenhardt W
      – PersonEntity:
          Name:
            NameFull: Rummel M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2152-2669
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical lymphoma, myeloma & leukemia
              Type: main
ResultId 1